Our platform for fostering conversation on product development and product lifecycle management topics of interest with the community.
published on February 28, 2020 by
published on June 13, 2018 by
I was once told by a serial Life Sciences Entrepreneur (with both Biotech & MedTech exits) that when it comes to taking care of their young (early stage ventures) the Biotech industry is “mammalian” and MedTech industry is “reptilian”. In other words, Biotech/Pharma nurtures their young (In-licensing/Out-licensing deals) and MedTech eats their young (acquisition/do not commercialize).
published on August 17, 2017 by
The next 25 years will present incredible opportunities for innovators in the MedTech industry. In my opinion, individuals and teams who learn to operate with the “Hipster, Hacker, and Hustler” mindset will be in the best position to create game-changing innovation and become sought-after partners in future MedTech innovations. Unfortunately, this mindset is a bit foreign to many folks who have already been in the MedTech industry for a while---and professional investors “know it when they see it”.